BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 89 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,000 | -50.0% | 10 | -47.4% | 0.00% | – |
Q2 2020 | $2,000 | +100.0% | 19 | +18.8% | 0.00% | – |
Q1 2020 | $1,000 | -96.4% | 16 | -96.7% | 0.00% | – |
Q4 2019 | $28,000 | +366.7% | 481 | +304.2% | 0.00% | – |
Q3 2019 | $6,000 | +50.0% | 119 | +77.6% | 0.00% | – |
Q1 2019 | $4,000 | +33.3% | 67 | +31.4% | 0.00% | – |
Q4 2018 | $3,000 | -40.0% | 51 | -37.8% | 0.00% | – |
Q3 2018 | $5,000 | – | 82 | +645.5% | 0.00% | – |
Q2 2018 | $0 | – | 11 | +57.1% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 7 | -98.4% | 0.00% | – |
Q3 2017 | $20,000 | +400.0% | 430 | +505.6% | 0.00% | – |
Q2 2017 | $4,000 | -71.4% | 71 | -70.9% | 0.00% | – |
Q1 2017 | $14,000 | -6.7% | 244 | -9.0% | 0.00% | – |
Q4 2016 | $15,000 | +650.0% | 268 | +370.2% | 0.00% | – |
Q3 2016 | $2,000 | 0.0% | 57 | +14.0% | 0.00% | – |
Q2 2016 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | – |
Q1 2016 | $2,000 | -60.0% | 50 | -54.5% | 0.00% | – |
Q4 2015 | $5,000 | -61.5% | 110 | -65.0% | 0.00% | – |
Q3 2015 | $13,000 | -18.8% | 314 | +7.2% | 0.00% | – |
Q2 2015 | $16,000 | +300.0% | 293 | +176.4% | 0.00% | – |
Q1 2015 | $4,000 | +300.0% | 106 | +231.2% | 0.00% | – |
Q4 2014 | $1,000 | -80.0% | 32 | -84.0% | 0.00% | – |
Q2 2014 | $5,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |